The Economic Burden of Dialysis Patients in Belgium: a Comparison Between Haemo and Peritoneal Dialysis
Pp. 208-222 (15)
Max Dratwa, Anne-Marie Bogaert, Koen Bouman, Xavier Warling, Remi Hombrouckx, Mario Schurgers, Pierre Dupont, Anne Vereerstraeten, Guy Van Roost, Karin Caekelbergh, Mark Lamotte and Suzanne Laplante
Abstract
The number of patients on dialysis has increased by about 50% in the past
decade in Belgium. This growth is expected to continue, albeit at a slower pace, due to
the ageing of the population and the increased prevalence of hypertension and diabetes,
two of the main causes of end-stage kidney disease. The aim of this study was to assess
the economic burden (i.e., dialysis procedure; hospitalizations; ambulatory care;
medications; transport) to the public healthcare payer of patients undergoing dialysis in
Belgium. Records of 130 Belgian patients on dialysis in 2006 were retrospectively
reviewed to identify direct medical and non-medical resources used over a year. Official
tariffs were used to cost the resources. Considering the prevalence of each dialysis
modality in Belgium, the average cost of a dialysis patient was found to be €70,649 per
year (haemodialysis: €72,350; peritoneal dialysis: €55,343). The dialysis procedure
itself was the main cost driver (66% of all costs) followed by hospitalizations and
ambulatory care (16% of all costs each). The dialysis procedure per se was 27% more
expensive, while hospital and ambulatory services were respectively 28% and 45%
more expensive for haemodialysis than peritoneal dialysis patients. Considering that
there were 6,607 patients on dialysis in Belgium (0.06% of the Belgian population) at
the end of 2006, it is estimated that the economic burden to the Belgian healthcare
system was 467 million Euro or 2.45% of the healthcare budget. This study provides
further evidence that home modalities, such as peritoneal dialysis, could help reduce the
economic burden of dialysis on the healthcare budget.
Keywords:
Dialysis, haemodialysis, home dialysis, peritoneal dialysis, healthcare
costs, Belgium, economic burden.
Affiliation:
Health Economics and Outcomes Research, IMS Health, Medialaan 38, Vilvoorde, Belgium.